Mice lacking 1,4,5-triphosphate inositol type III receptor demonstrate inhibition of hypoxic pulmonary hypertension

Inhibition of IP3R3 attenuates endothelial to mesenchymal transition induced by TGF-β1 through restoring mitochondrial function

(2022) Yahang Xu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MiR-204 regulates type 1 IP3R to control vascular smooth muscle cell contractility and blood pressure

(2019) Mohanad Gabani et al.   CELL CALCIUM

Type 2 inositol 1,4,5-trisphosphate receptor inhibits the progression of pulmonary arterial hypertension via calcium signaling and apoptosis

(2018) Akimichi Shibata et al.   HEART AND VESSELS

Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension

(2017) A.A. Roger Thompson et al.   TRENDS IN MOLECULAR MEDICINE

Downregulation of type 3 inositol (1,4,5)-trisphosphate receptor decreases breast cancer cell migration through an oscillatory Ca2+ signal

(2017) Abdallah Mound et al.   Oncotarget

Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathways

(2016) Simon C Rowan et al.   Lancet Respiratory Medicine

The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes

(2015) Steven C. Pugliese et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Hypoxic Pulmonary Vasoconstriction

(2012) J. T. Sylvester et al.   PHYSIOLOGICAL REVIEWS

Inositol trisphosphate and calcium signalling mechanisms

(2008) Michael J. Berridge   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH